Final Results of 406 Patients with Short-Term Infusion CH14.18/CHO Randomised for Subcutaneous Aldesleukin and Results in 161 Confirmatory Patients: The Current SIOPEN HR-NBL1 Front-Line Experience
PEDIATRIC BLOOD & CANCER（2016）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要